Bayer Drug, Xarelto Faces 18,000 Lawsuits*
By Ariana Marisol
The first court test of Bayer/J&J’s blood thinner, Xarelto, is coming up in New Orleans next week. The outcome will influence how the 18,000 lawsuits behind it will be handled.
Joseph Boudreaux is the plaintiff of the first suit. Xarelto was supposed to help cut his stroke risk, yet according to Bourdeaux, it caused internal bleeding that required a week-long hospital stay in ICU, several blood transfusions, and multiple heart procedures.
Lawyers for Bayer and J&J argue that Xarelto was approved by the FDA as safe and effective.
This argument is one that many drugmakers use when being accused of putting unsafe drugs on the market.
If the government deems it safe, does that relinquish Pharmaceutical companies of all responsibility? It shouldn’t. The FDA does not develop, manufacture, and sell drugs. Pharmaceutical companies do. If their drugs are making people more sick, these companies should be held responsible.
A simple law could place the blame where it should be placed. Regardless of what the FDA states, the ultimate accountability for a drug’s effects should lie with the company that created it.
If you create a product that has 18,000 people claiming your product seriously harmed them, you are the one who should be in court facing these allegations.
While the FDA is not necessarily the most trustworthy agency, they are the only body that can certify a drug for public use. Their assessment of a drug and approval of it should not exonerate the drug company for putting something dangerous on the market.
It is time that Pharmaceutical companies pay for the damage and harm they have caused people throughout the world. With 18,000 lawsuits pending, Bayer and J&J should be held accountable.